New treatment approaches in chronic kidney disease-associated anaemia

Author： Del Vecchio Lucia   Locatelli Francesco  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.14, Iss.5, 2014-05, pp. : 687-696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Darbepoetin alfa: a new therapy for the management of anaemia associated with chronic kidney disease

By Lindberg Jill  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 977-984

Informa Healthcare

Access to resources Recommend Favorite

Changes of urinary phospholipids in the chronic kidney disease patients

By Yang Wen-Ling   Bai Qiong   Li Dan-Dan   A Ta-La   Wang Song   Zhao Rong-Sheng   Nie Hong-Gang   Zhang Ai-Hua   Wang Tao   Fan Min-Hua  

Biomarkers, Vol. 18, Iss. 7, 2013-11 ,pp. : 601-606

Informa Healthcare

Access to resources Recommend Favorite

Role of Asymmetric Dimethylarginine (ADMA) in Chronic Kidney Disease

By  

Current Enzyme Inhibition, Vol. 3, Iss. 4, 2007-11 ,pp. : 284-290

Bentham Science Publishers

Access to resources Recommend Favorite

Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia

By Vansteenkiste Johan   Rossi Gregory   Foote MaryAnn  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 3, 2003-06 ,pp. : 501-508

Informa Healthcare

Access to resources Recommend Favorite

Clinical and research markers of oxidative stress in chronic kidney disease

By Tucker Patrick Steven  

Biomarkers, Vol. 18, Iss. 2, 2013-03 ,pp. : 103-115

Informa Healthcare

Access to resources Recommend Favorite